T1	Intervention 472 569	3 groups: 1) Intradermal group (ID Group), 42 patients given an intradermal injections of OK-432.
T2	Intervention 570 723	2) Intramuscular group (IM Group), 40 patients given an intramuscular injections of OK-432. 3) Control group (C Group), 39 patients not given injections.
